Viewing Study NCT00796159


Ignite Creation Date: 2025-12-24 @ 2:29 PM
Ignite Modification Date: 2026-01-01 @ 8:16 PM
Study NCT ID: NCT00796159
Status: COMPLETED
Last Update Posted: 2009-12-23
First Post: 2008-11-20
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Post-Marketing Surveillance Of Olmesartan Medoxomil In Combination With Hydrochlorothiazide
Sponsor: Pfizer
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module